Seaport Therapeutics, Inc.
SPTX
$24.22
$0.512.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -62.60M | -25.41M | -15.08M | ||
| Total Depreciation and Amortization | 351.00K | 357.00K | 354.00K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 36.50M | 2.35M | 572.00K | ||
| Change in Net Operating Assets | -396.00K | 2.53M | -1.17M | ||
| Cash from Operations | -26.14M | -20.17M | -15.33M | ||
| Capital Expenditure | -- | -- | -269.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -203.50M | 27.85M | -1.17M | ||
| Cash from Investing | -203.50M | 27.85M | -1.44M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 240.15M | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 783.00K | -783.00K | -- | ||
| Cash from Financing | 240.93M | -783.00K | -- | ||
| Foreign Exchange rate Adjustments | 29.00K | -28.00K | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 11.31M | 6.87M | -16.77M | ||